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Chemical modifications of RNA molecules have gained increasing attention since evidence 
emerged for their substantive roles in a range of bi logical processes, such as the stability 
and translation of mRNA transcripts. More than 150 modifications have been identified in 
different organisms to date, collectively known as the ‘epitranscriptome’, with 6-
methyladenosine (m6A), 5-methylcytidine (m5C), pseudouridine and N1-methyladenosine 
(m1A) the most extensively investigated. Although we ar just beginning to elucidate the 
roles of these modifications in cellular functions, there is already evidence for their 
dysregulation in diseases such as cancer and neurodevel pmental disorders. There is 
currently more limited knowledge regarding how environmental exposures affect the 
epitranscriptome and how this may mediate disease risk, but evidence is beginning to 
emerge. Here, we review the current evidence for the impact of environmental exposures 
such as benzo[a]pyrene, bisphenol A, pesticides, metals and nanoparticles upon RNA 
modifications and the expression of their ‘writers’ (methyl transferases), ‘erasers’ 
(demethylases) and ‘readers’ . We discuss future directions of the field and identify areas of 
particular promise and consider the technical challenges that are faced.  
 











1. Introduction  
Environmental epigenetics studies the effects of enviro mental exposures upon the 
epigenome in relation to human health and disease risk. There is now extensive evidence to 
suggest that a variety of environmental exposures alt r epigenetic marks such as DNA 5-
methylcytocine (m5C) and histone modifications, thereby potentially modulating gene 
transcription. It is now recognised that RNA molecul s undergo similar modifications. To 
date, more than 150 different modifications of coding and non-coding RNAs have been 
reported (Boccaletto et al., 2018), collectively refe red to as “RNA epigenetics” (He, 2010) or 
the “epitranscriptome” (Saletore et al., 2012). Similar to DNA and histone modifications, 
RNA modifications are maintained by proteins serving as writers, readers, and erasers. 
“Writers” are comprised of transferase enzymes that facilitate addition of chemical groups to 
RNA bases, such as METTL3 (methyltransferase like 3), METTL14 (methyltransferase like 
14), METTL16 (methyltransferase like 16), RBM15 (RNA binding motif protein 15), WTAP 
(wilms tumor 1-associating protein), and KIAA1429( vir like m6A methyltransferase 
associated). These are removed by “erasers”, such as FTO/ALKBH9 (alpha-ketoglutarate 
dependent dioxygenase) and ALKBH5 (alkb homolog 5, RNA demethylase). The RNA 
modifications are recognised and utilised by "readers”, such as HNRNPC (heterogeneous 
nuclear ribonucleoprotein C), HNRNPA2B1 (heterogeneous nuclear ribonucleoprotein 
A2/B1), YTHDF2 (YTH N6-Methyladenosine RNA binding protein 2), YTHDF1 (YTH N6-
Methyladenosine RNA binding protein 1), and eIF3 (eukaryotic initiation factor 3). The most 
widely studied of these to date are those which modulate m6A, m5C, and m1A RNA 
methylation.   
Epitranscriptomics is emerging as a field of great interest. As with epigenetics, much of 
the early research has focused on human diseases, epecially cancer. However, there is 
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currently much more limited data available regarding how environmental exposures alter 
RNA modifications. Here, we review the evidence for the alteration of RNA modifications in 
disease and in response to a range of exposures, evaluating the work from in vitro, animal 
model and human population studies. 
 
2. Types of RNA modification 
The first modification in RNAs was discovered in 1957 (Davis and Allen, 1957). Since then, 
more than 150 different RNA modifications have been reported in a wide range of organisms 
(Gilbert et al., 2016), including m6A, N6,2'-O-dimethyladenosine, m5C, 5-
hydroxylmethylcytidine (hm5C), inosine, pseudouridine, and m1A in eukaryotic organisms 
(Dominissini et al., 2012; Meyer et al., 2012). Here, we will briefly introduce three of the 
most widely studied modifications m6A, m1A and m5C (Figure 1), that through 
transcriptome-wide studies have been demonstrated to be present in tRNAs, rRNAs, mRNAs, 
long noncoding RNAs, miRNAs, and circRNAs (Dominissini et al., 2012; Meyer et al., 
2012). 
 
2.1 6-methyladenosine (m6A)  
m6A was firstly discovered in polyadenylated RNA in ma malian cells in 1970, and it was 
the first RNA modification to have its writers, erasers and readers characterised (Cao et al., 
2016). It is highly abundant in mRNA, more so than any other mRNA modification, with two 
recent studies identifying m6A modifications in the mRNAs of over 7,600 protein-coding 
genes and more than 300 non-coding RNAs, with significa t enrichment within the 3’ UTR 
(Dominissini et al., 2012; Meyer et al., 2012). This modification is associated with RNA 
splicing (Little et al., 2000; Ping et al., 2014; Zheng et al., 2013), stability (Geula et al., 2015; 
Wang et al., 2014) and mRNA decay (Cao et al., 2016), and therefore is important in post-
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transcriptional regulation of gene expression. The writers and readers of m6A modifications 
have been linked to specific biological functions, with WTAP involved in mRNA splicing 
(Little et al., 2000; Ping et al., 2014; Zheng et al., 2013), YTHDF1 and eIF3 in the translation 
process (Meyer et al., 2015; Wang et al., 2015), and YTHDF2 in mRNA decay (Cao et al., 
2016). Subsequently, disruptions of those genes that control RNA m6A methylation levels are 
related to human diseases and disorders such as obesity, type 2 diabetes (Dina et al., 2007; 
Frayling et al., 2007; Klungland and Dahl, 2014; Scuteri et al., 2007) and neurological 
diseases (McGuinness and McGuinness, 2014), while canges in m6A levels have been 
identified in infertility, carcinogenesis, meiosis, and in relation to stemness (Fu et al., 2014).  
 
2.2 N1-methyladenosine (m1A)  
First reported in 1961 (Dunn, 1961), the m1A RNA modification has been identified in tRNA 
(RajBhandary et al., 1966), rRNA (Sharma et al., 2013), mRNA (Dominissini et al., 2016) 
and in mitochondrial (mt) transcripts (Li et al., 2017a), yet its various biological functions 
have only recently begun to be established. In humans, the m1A modification at position 58 
of tRNA molecules is written by the TRMT6/TRMT61 heterodimer and demethylated by 
ALKBH1, and it serves to promote the initiation of translation (Liu et al., 2016). m1A in 
mRNA is also believed to impact upon translation, with modifications near to the 5′ cap and 
5′ UTR in nuclear transcripts promoting their translation (Li et al., 2017a), but elsewhere it 
may inhibit translation by interruption of Watson-Crick base pairing (Li et al., 2017a; Morena 
et al., 2018). Nuclear and mitochondrial RNA molecus are chemically modified by distinct 
enzymes, with nuclear m1A in pre-tRNAs and some pre-mRNAs written by the tRNA m1A 
methyltransferase complex TRMT6/TRMT61A and erased by AlkB homolog proteins 
ALKBH1 and ALKBH3, while in mitochondria mt-tRNAs and a subset of mt-mRNAs are 






2.3 5-methylcytocine (m5C) 
The m5C modification is one of the most common in RNAs. Recent high-throughput RNA 
methylation profiling by bisulfite sequencing in HeLa cells has identified m5C at more than 
240 sites in tRNAs and 10,275 candidate sites in mRNAs and non-coding RNAs (Jühling et 
al., 2009; Squires et al., 2012). In contrast, there appear to be relatively fewer m5C residues in 
eukaryotic rRNAs, with human 28S rRNA containing only two m5C nucleotides at position 
4413/4 and 3761 (Maden, B.E. 1988) and none in 18S rRNA (Maden, B. E. 1986). 
 There are 28 known m5C sites in human tRNA (Jühling et al., 2009), of which 27 
have been verified by next-generation sequencing (Squires et al., 2012). For the best-
studied eukaryotic tRNAs, m5C residues are clustered in the junction between th variable 
region and TC-stem, with positions 48 and 49 the most frequently modified. Other locations 
in the anticodon loop (positions 34 and 38) have also been identified. Higher eukaryotes 
frequently have an additional m5C residue in the tRNA acceptor stem at position 72. 
  These modifications are in part written by DNA methyltransferase 2 (DNMT2), a 
methyltransferase enzyme that was first described as methylating the cytosine at position 38 
in tRNAAsp, and NSUN2 that methylates the 5th position of cytosines in tRNAs, ncRNAs, and 
vault-associated RNAs. However, there are a wider range of methyltransferases, including 
NSUN1 (NOP2), NSUN3, NSUN4, NSUN5, NSUN6 and NSUN7,  that are known to 
methylate different RNAs in distinct cellular localizations (Bohnsack et al., 2019). 
 There is now evidence pointing to a critical role for tRNA and rRNA modifications in 
cellular responses to stimuli, demonstrating roles in tRNA stability (Alexandrov et al., 2006; 
Motorin and Helm, 2010), cellular stress responses (B gley et al., 2007; Netzer et al., 2009; 
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Thompson and Parker, 2009) and cell growth (Emilsson et al., 1992). In general, tRNA 
modifications enhance ribosome binding affinity, reduce misreading and modulate frame-
shifting, all of which affect the rate and fidelity of translation (Chan et al., 2012). As most 
tRNA m5C sites are located around the variable region and anticodon loop, this methylation 
stabilizes tRNA secondary structure, affects aminoacylation and codon recognition, and 
confers metabolic stability (Liebers et al., 2014). 
 Additionally, ribosomal RNA methylation has been shown to be involved in 
translational fidelity and tRNA recognition (Liebers et al., 2014). Loss of vault RNA 
methylation in NSun2-deficient mice causes aberrant vault processing into Argonaute-
associated small RNAs, as well as aberrant expression of several mRNAs that are the putative 
targets of vault-derived small RNAs (Hussain et al., 2013). These findings provided the first 
mechanistic insight into the role of RNA methylation in gene regulation. DNMT2-mediated 
methylation has also been shown to protect substrate tRNAs against endonucleolytic cleavage 
(Liebers et al., 2014), with lack of Dnmt2 and NSun2 and subsequent tRNA hypomethylation 
associated with decreased tRNA levels and a significa t reduction in protein translation rates 
(Liebers et al., 2014).  
 
3. Epitranscriptomics in disease 
3.1 Cancer 
As with the field of epigenetics, much of the early work in epitranscriptomics has related to 
malignancies, with identification of both disruption f normal RNA modification patterns and 
changes in the expression of their writers, erasers and readers. In particular, the m6A 




 The METTL3/METTL14-mediated addition of m6A to pluripotency-associated 
mRNAs results in their breakdown, and thereby promotes cellular differentiation of mouse 
embryonic stem cells (Geula et al., 2015). However, in contrast to this, METTL3 and 
METTL14 are very highly expressed in haematopoietic stem cells and show reduced 
expression in more differentiated myeloid cells (Barbieri et al., 2017). The expression and 
activity of these m6A writers is also high in acute myeloid leukaemia (AML) and appears to 
have a key in maintaining the stemness of the malign nt cells, with knockdown of these 
genes resulting in growth arrest via changes in the m6A content of transcripts associated with 
the cell cycle and c-myc (Barbieri et al., 2017). The m6A eraser FTO is also up-regulated and 
plays a critical oncogenic role in AML, in part by demethylating and thereby down-regulating 
the tumour-suppressors ASB2 and RARA (Li et al., 2017b). Together these studies 
demonstrate the complexity in understanding the impact of RNA modifications and the 
dysregulation of RNA methylation machinery, with transcript-specific effects. 
 Similar to AML, m6A writers and erasers are implicated in the maintenance of 
stemness in glioblastoma. The m6A eraser ALKBH5 is highly expressed in glioblastoma 
stem-like cells (GSCs), and its silencing suppresses proliferation of patient-derived GSCs  (Li 
et al., 2017a). This is supported by evidence that knockdown of the eraser FTO suppresses 
tumour progression, while the knockdown of the writers METTL3 and METTL14 promotes 
human GSC growth, self-renewal and tumorigenesis, (Cui et al., 2017). These associations 
appear to be driven by the regulation of m6A near the start and stop codons of transcripts 
relating to GSC self-renewal, such as ADAM19.  
 The tumour microenvironment may influence the cancer epitranscriptome. Hypoxia is 
associated with increased expression of  ALKBH5, leading to demethylation and increased 
stability of the NANOG transcription factor that promotes pluripotency (Zhang et al., 2016), 
9 
 
and induces the ZNF217-mediated inhibition of  the RNA methylation writer complex 
(Zhang et al., 2016). 
 There is also evidence for disruption of m5C in malignancies. The NSUN2-mediated 
methylation of oncogenic mRNAs in bladder tumours promotes their stability and translation, 
thereby facilitating progression of the disease (Chen et al., 2019b), while NSUN2 expression 
is up-regulated in breast cancer and promoters cell pro iferation and invasion (Yi et al., 
2017). The cause of NSUN2 up-regulation in solid tumo rs such as colorectal and oral 
cancers can be increased copy number (Okamoto et al., 2012). There is already emerging 
evidence for an impact of RNA m5C on drug sensitivity (Cheng et al., 2018), suggesting that 
this may be a fruitful avenue of research in the near future. 
 
3.2 Non-malignant disease 
There is more limited evidence for changes in RNA m5C methylation in non-malignant 
diseases, but this is likely to change soon as the field becomes more established. Most of the 
evidence to date comes from analysis of genetic variant within genes encoding m5C writers. 
Several studies have demonstrated that DNMT2 mutations or knockdown are implicated in 
neurodevelopmental and neuronal disorders in zebrafish, drosophila, yeast (Angelova et al., 
2018). In humans, studies have identified polymorphisms in DNMT2 that are associated with 
spina bifida (Franke et al., 2009), and mutations i NSUN2 and aberrant methylation of 
tRNAs associated with intellectual disability and Dubowitz-like syndrome (Abbasi-Moheb et 
al., 2012; Blanco et al., 2014; Huber et al., 2011; Martinez et al., 2012). However, there is 
currently a lack of data regarding the functional impact of such genetic variants and somatic 
mutations. One of the key challenges in the coming years will be to establish what these 




4. Environmental exposures 
As evidence is acquired for disruption of RNA modification processes in a range of diseases 
and disorders, there will undoubtedly be increasing interest in the impact of environmental 
exposures upon the epitranscriptome and how they may mediate disease risk. Here, we will 
review the current evidence for the effect of different exposures on RNA m6A, m1A and m5C. 
In a number of cases, this evidence is comprised of altered expression of RNA methylation 
writers, erasers and readers as identified through gene expression microarrays, without 
further examination of functional impact. Several interactions including gene/protein 
interactions, chemical–disease and gene-disease relationships (http://ctdbase.org/) were 
reviewed by means of publicly available data from the Comparative Toxicogenomics 
Database (CTD) supported by the National Institute of Environmental Health Sciences 
(NIEHS) (Davis et al., 2018). We included all types of studies (cell culture, animal models, 
and human) that were related to changes in gene expression and/or DNA methylation in 
response to environmental exposures. We included studies that provided significant results 
for genes encoding RNA methylation modulators (i.e. writers, erasers and readers) for m6A, 
m1A, and m5C. 
 
4.1 Benzo(a)pyrene 
Polycyclic aromatic hydrocarbons (PAHs) are formed after the incomplete combustion of 
organic materials, and many are known as carcinogenic, toxic, mutagenic, teratogenic, and 
immune system suppressors. One such compound, benzo[a]pyrene (BaP), is a mutagenic 
carcinogen that is ubiquitous in the environment. Most studies to date have demonstrated an 
effect of BaP on the expression of RNA m6A modification enzymes through in vitro and in 
vivo studies (summarized in Table 1). These studies have typically reported increased 
expression of the writers METTL3 and WTAP (Hooven and Baird, 2008; Jennen et al., 2010; 
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Kerley-Hamilton et al., 2012; Magkoufopoulou et al., 2011; Malik et al., 2012; Mathijs et al., 
2009; Perez et al., 2008; Qiu et al., 2011; Shi et al., 2010; Souza et al., 2016) and the readers 
HNRNPC, HNRNPA2B1 and YTHDF2 (Hooven and Baird, 2008; Jennen et al., 2010; 
Kerley-Hamilton et al., 2012; Magkoufopoulou et al., 2011; Malik et al., 2012; Mathijs et al., 
2009; Perez et al., 2008; Qiu et al., 2011; Shi et al., 2010; Souza et al., 2016), while reporting 
reduced expression of the eraser FTO (Hooven and Bair , 2008; Jennen et al., 2010; Kerley-
Hamilton et al., 2012; Magkoufopoulou et al., 2011; Malik et al., 2012; Mathijs et al., 2009; 
Perez et al., 2008; Qiu et al., 2011; Shi et al., 2010; Souza et al., 2016). While this suggests 
that there may be increased abundance of m6A in response to BaP exposure, there is currently 
no data on the direct measurement of this. 
Similarly, there is evidence for altered expression of m1A and m5C modifier enzymes in 
response to BaP exposure, but no data directly measuring the functional consequences of this. 
Two studies have reported altered expression of TRM6, TRMT10C, and TRMT61B 
following BaP exposure (Kerley-Hamilton et al., 201; Magkoufopoulou et al., 2011). 
Interestingly, Severson and colleagues have also demonstrated that BaP exposure induces 
mutations in the TRMT6 gene, amongst others, although the functional consequences of this 
were not explored (Severson et al., 2014). There is conflicting evidence for the effect of BaP 
upon expression of m5C writers, with increased expression of NOP2 and decreased 
expression of NSUN4 having been reported (Mathijs et al., 2009; Souza et al., 2016).  
 
4.2 Aflatoxin B1 
Two Aspergillus species produce aflatoxins, which are have been declared as Group 1 
carcinogens in humans by IARC (IARC, 1993). The liver is the main target organ of 
aflatoxins, and aflatoxin B1 exposure has been shown t  downregulate expression of the m6A 
eraser FTO in primary human hepatocytes (Rieswijk et al., 2016). A number of m1A 
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modifiers also show differential expression, including increased expression of TRMT6 in the 
HepaRG cell line (Josse et al., 2012) and upregulation of ALKBH1 and TRMT61B in 
primary mouse hepatocytes (Mathijs et al., 2009). The NOP2 m5C writer has also been 
reported to be upregulated  (Rieswijk et al., 2016). However, as with BaP, to date there have 
been no studies measuring the impact of these changes upon RNA modifications. 
 
4.3 Bisphenol A 
Bisphenol A (BPA) is an endocrine-disrupting chemical with oestrogenic properties 
(Beausoleil et al., 2018). BPA is used in many common products including plastics and 
bottles, food and beverage cans, and sports equipment. There is evidence for disruption of 
RNA modifier genes in response to BPA exposure (summarised in Table 2), but these studies 
have reported contrasting findings. Importantly, BPA is one of the few exposures for which 
an impact upon RNA modifications has been demonstrated. 
Mahemuti and colleagues (Mahemuti et al., 2018) provided evidence for an effect in 
human-derived material, reporting decreased expression of the m6A, m1A and m5C writers 
METTL3, TRTM6 and NSUN2 and decreased expression of the m6A readers HNRNPC and 
HNRNPA2B1 in cultured lung fibroblasts. These results may imply wide-ranging effects 
upon RNA modifications in the cells, on account of down-regulation of writers of three 
different modifications. However, in contrast to this, Ali and colleagues (Ali et al., 2014) 
have reported upregulation of the writers Mettl3, Wtap, Trmt6, Trmt61a  and Nsun2 and the 
readers Hnrnpc and Ythdf2 in rat testes, along with decreased expression of the erasers Fto 
and Alkbh1, suggesting a potential increase in m6A abundance and utilisation in the tissue. 
Upregulation of the readers Hnrnpa2b1 and Ythdf1 have also been reported in rat heart and 
breast tissue (Ali et al., 2014; Jadhav et al., 2017; Ljunggren et al., 2016; Mahemuti et al., 
2018; Tait et al., 2015). Crucially, however, we have provided evidence that exposure to BPA 
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is associated with decreased global m6A in the A549 human lung adenocarcinoma cell line 
(Cayir et al., 2019), thereby potentially supporting the findings of Mahemuti and colleagues 
in cultured cells from the same tissue. Our study is, to date, one of the very few to 
demonstrate an impact of environmental exposures upon the epitranscriptome. Nonetheless, it 
remains to be established whether the conflicting fi dings represent tissue-specific (e.g. 
hormone-sensitive tissues) or species-specific effects, or indeed whether they are the product 
of study design (in vitro versus in vivo). 
4.4 Tetrachlorodibenzo-p-dioxin 
Tetrachlorodibenzo-p-dioxin (TCDD) was classified as Group 1 carcinogen in humans by 
IARC in 1997 (Steenland et al., 2004), produced as a by-product of the burning of organic 
material. Work in animal models has demonstrated that TCDD exposure is associated with 
increased expression of the m6A writer Wtap in the mouse brain (Gohlke et al., 2009; 
Rasinger et al., 2014) and the m5C writer Nsun2 in rat and mouse liver (Boutros et al., 2008), 
but decreased expression of the m6A reader Hnrnpc in mice uterine tissue (Gohlke et al., 
2009; Neri et al., 2011; Rasinger et al., 2014; Thornley et al., 2011). In support of this, 
WTAP and METTL3 have been shown to be overexpressed in cultured human hepatocytes 
following TCDD exposure (Gohlke et al., 2009; Neri t al., 2011; Rasinger et al., 2014; 
Thornley et al., 2011). Together this may suggest promotion of m6A methylation of RNA in 
response to exposure, but once again data is lacking to support such a hypothesis. In contrast 
to this, there have been conflicting findings regarding m1A modifiers, with Boutros and 
colleagues reporting reduced expression of both Trmt10c and Alkbh1 in rat liver (Boutros et 
al., 2011), while Lee et al reported increased Alkbh1 expression in mouse liver (L e et al., 






Pesticides have been associated with changes in the mal  reproductive system through 
affecting genomic imprinting in sperm (Stouder and Paoloni-Giacobino, 2010) and 
transgenerational disorders due to other epigenetic alterations (Anway et al., 2006), and even 
affecting spermatogenic capacity in adults who were xposed during foetal development 
(Uzumcu et al., 2004). Furthermore, exposure has been linked to cancer, neurodegenerative 
disorders and endocrine disruption (Bolognesi et al., 2011; Mostafalou and Abdollahi, 2013; 
Owens et al., 2010). Four pesticides whose impact upon the epitranscriptome have been 
analysed are atrazine, diuron, diazinon, and vinclozolin (summarised in Table 3). 
Atrazine is one of the most widely used herbicides. However, early studies have not 
clarified a clear role for this pesticide in disruption of RNA modifications. In cell lines and 
primary cells, studies have variously reported atrazine as downregulating the expression of 
m6A, m1A and m5C writers and erasers and upregulating readers (Kooet al., 2012; Midic et 
al., 2016; Wirbisky et al., 2015). However, work in zebrafish embryos has contradicted these 
findings, with increased expression of METTL14, ALKBH5 and TRMT6 (Wirbisky et al., 
2015). Another herbicide, diuron, has been reported to increase expression of the m5C writer 
Nsun4 in the rat urinary bladder (Ihlaseh et al., 2011). With these studies presenting 
contrasting findings, and often simultaneously repoting increased or decreased expression of 
both writers and erasers, few conclusions can be drawn at this time.  
Diazinon is an organophosphate insecticide that is commonly used by homeowners, but 
which was classified by IARC in 2015 as "probably carcinogenic to humans" (Group 2A) 
(Guyton et al., 2015). To date, there have been two studies regarding the regulation of m5C 
modification-related genes with diazinon exposure. While in vitro work has revealed 
promoter hypermethylation of the writer NSUN5 in the K562 cell line (Zhang et al., 2012), 
NSUN4 expression has been shown to be increased in SH-SY5Y cells (Koo et al., 2012). 
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These results are not necessarily contradictory, as while promoter methylation is commonly 
associated with gene silencing there was no evaluation of its impact in the K562 cells, and 
DNA methylation can also be associated with increased gene expression. 
In our aforementioned study of the impact of carcinogens and endocrine disruptors on 
m6A methylation in A549 cells (Cayir et al., 2019), we demonstrated that vinclozolin, a 
widely used pesticide, decreased m6A in a dose-response manner. This to date remains the 
only direct evidence for an effect of pesticides upon the epitranscriptome. It may be seen as 
supported by evidence of decreased expression of the m6A reader Hnrnpa2b1 in the rat ovary 
(Nilsson et al., 2012), but other work from the same group has revealed increased expression 
of the same gene in rat testes following the same exposure (Guerrero-Bosagna et al., 2013). 
This suggests a tissue-specific effect of the pesticide and underlines the need for caution 
when extrapolating results from cell lines. While these studies suggest that vinclozolin 
exposure warrants further examination, it is still to be established whether m6A is disrupted in 
exposed organisms. In addition to m6A, there is some limited evidence that modifiers of m1A 
may also be affected, with increased expression of tRNA methyltransferases in a variety of 
different rat tissues (Skinner et al., 2012), but decreased in the brain (Crews et al., 2012). 
 
4.6 Metals 
Metals are among the most widely studied exposures in relation to the expression of RNA 
modifier genes. The findings of studies examining a range of metal exposures are 
summarised in Table 4.  
 Arsenic is classified as carcinogenic to humans by IARC (IARC, 2004) and is 
associated with malignancies of lung, skin and bladder, in addition to being implicated in 
cardiovascular diseases (Navas-Acien et al., 2005) and neurodegenerative disease (Vahidnia 
et al., 2007). Arsenic compounds can be found in the air, soil and water, and exposure to 
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them is known to lead to DNA methylation changes (Jomova et al., 2011). There is now 
emerging evidence from in vitro studies for an impact on the epitranscriptome as well. We 
have recently demonstrated that exposure to sodium arsenite leads to a dose-response 
reduction in m6A in A549 lung adenocarcinoma cells (Cayir et al., 2019). This is supported 
by gene expression studies conducted elsewhere that have identified decreased METTL3 
expression in NB4 leukaemic cells (Zheng et al., 2005) and decreased WTAP expression in 
non-malignant lung epithelial cells (Clancy et al., 2012). Interestingly, the level of arsenite 
exposure may impact upon m6A levels, as Chen and colleagues reported an increase ( nd 
increased expression of m6A writers) with low levels of exposure but decreased m6A in 
response to higher exposures (Chen et al., 2019a). The duration of exposure may also be 
crucial, as extended exposure (13 weeks) has been rported to increase m6A levels in 
bronchial epithelial cells (Gu et al., 2018), and has also been reported in neuronal cells 
following six months of exposure (Bai et al., 2018). While sodium arsenite is perhaps the best 
studied environmental exposure in relation to the epitranscriptome, there are already 
apparently-conflicting results that demand further analysis. Nonetheless, the observation of 
changes in global RNA m6A levels in these in vitro studies marks sodium arsenite as a 
potentially promising area of future research. Work will need to be conducted in animal 
models and human population studies to confirm these in vitro findings, and transcript-
specific analysis will need to be performed to understand the functional consequences. 
 Another potentially fruitful avenue of future research is in the effects of copper 
exposure. Independent in vitro studies from two groups using human liver and lung cell lines 
have similarly revealed increased expression of the m6A writer METTL14 (Song et al., 
2009), while elsewhere the reader HNRNPA2B1 has been shown to be similarly upregulated 
(Armendariz et al., 2006). The latter is supported by in vivo findings of increased Hnrnpa2b1 
expression in mouse liver (Burkhead et al., 2011). The impact upon m1A is less clear, as Song 
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and colleagues reported decreased expression of an m1A writer (TRMT61B) and eraser 
(ALKBH1) in the same study (Song et al., 2009). 
 In addition to these studies with arsenic and copper, there is more limited in vitro 
evidence for an impact of cobaltous chloride (Hang et al., 2009; Permenter et al., 2013) and 
potassium chromate (VI) (Wu et al., 2012) upon m6A erasers and readers, while studies in 
zebrafish have revealed decreased expression of the m1A eraser ALKBH3 in response to 
methylmercury chloride (Ho et al., 2013; Yang et al., 2007) and increased expression of the 
m5C writer NOP2 (Hussainzada et al., 2014). There has been very little study in human 
populations, not only for metals but for most exposure types, yet there is emerging evidence 
from three independent studies that nickel exposure i  associated with increased expression of 
the m5C writers NOP2 and NSUN4 (da Rosa et al., 2015; Dhingra et al., 2014), and that 
NSUN3 is upregulated in peripheral blood with lead xposure (LaBreche et al., 2011).  
 
4.7 Nanoparticles 
Early work on carbon nanotube exposure may suggest an increase in m6A and m1A 
abundance and utilisation. Gene expression profiling by microarray has revealed increased 
expression of Hnrnpa2b1, Trmt6 and Trmt61a in mouse liver (Poulsen et al., 2015a) and lung  
(Poulsen et al., 2015b), with upregulation of HNRNPA2B1 similarly reported in exposed 
non-malignant lung epithelial cells (Park et al., 2014) and observed at the protein level in a 
human liver cell line (Yuan et al., 2011). 
 
4.8 Others 
It should be noted that while the above represent some of the most widely studied exposures, 
there are of course others of emerging interest, with asbestos having been observed to affect 
the expression of WTAP in human pleural mesothelial cel s (Dragon et al., 2015) and the 
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heterocyclic compound furan has been shown to induce the expression of Trmt61a in rat liver 
(Dong et al., 2016). It is expected that the coming years will see both strengthened 
examination of the epitranscriptome (as opposed to the expression of its regulators) and 




5. Conclusions and future directions 
Epitranscriptomics is an emerging field within molecular biology that is likely to see a sharp 
increase in interest in the next five years. As with the early studies of DNA methylation, 
much of the pioneering work has been performed in relation to human disease, and especially 
cancer. These studies have sought to understand the aberrant expression and activity of RNA 
methylation modifiers in malignancies and neurodevelopmental disorders, and to elucidate 
the subsequent impact on the translation of genes with key roles in their pathology. By 
contrast, environmental epitranscriptomics is at a very embryonic stage. To date there have 
been very few studies directly focused upon the expression of RNA methylation modifiers, 
and even fewer that have demonstrated an impact upon m6A, m1A or m5C modifications. 
Many of the studies we have presented within this review have reported changes in the 
expression of RNA methylation writers, erasers and readers in response to a range of 
exposures, but often as part of transcriptome-wide analysis and without detailed follow-up. 
Nonetheless, our review of the literature has indeed id ntified evidence for such changes, and 
we hope this will help to identify those exposures with the strongest evidence for an effect on 
the epitranscriptome. In our own work, we have demonstrated a dose-response with changes 
in global m6A levels in response to BPA, sodium arsenite, vinclozo in and particulate matter 
exposures (Cayir et al., 2019). In particular, our bservation with sodium arsenite exposure is 
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supported by expression-based studies conducted elswhere that have reported decreased 
expression of m6A writers (Clancy et al., 2012; Zheng et al., 2005). BPA also appears to 
warrant further attention, with tissue-specific effects likely to be seen. Although there is no 
data yet on changes to RNA modifications, there is vidence to suggest that the carcinogen 
BaP may impact upon the epitranscriptome, with several studies reporting concordant 
findings of increased expression of m6A writers and readers, and decreased expression of 
erasers. 
 Clearly, there is a need to address the dearth of studies directly measuring RNA 
modifications in response to exposures. However, such studies will be very challenging to 
perform, and this represents a significant barrier to progress within the field. Early work on 
malignancies such as AML and glioblastoma demonstrated transcript-specific alteration of 
RNA modifications, leading to up-regulation of transcripts associated with cell cycle 
progression and pro-survival signalling. While analysis of global m6A, m1A and m5C levels 
may offer some insight into the biological response to xposures, it will not be able to reveal 
key genes and pathways required to truly elucidate their impact; it is analogous to measuring 
global changes in DNA methylation and making inferences from this, rather than being able 
to perform gene-specific analysis by microarray or bisulfite-sequencing. Transcriptome-wide 
analysis of RNA modifications by techniques such as methylated RNA immunoprecipitation 
(MeRIP) sequencing are therefore highly preferable, ut they are expensive and require large 
quantities of purified mRNA (typically 300 µg of starting total RNA) that exceed what can be 
afforded by cohort studies. Furthermore, some have questioned the reproducibility of studies 
using such approaches (McIntyre et al., 2020). These issues currently prohibit the application 
of transcript-specific analysis to human population studies. One potential solution to this is to 
marry in vitro or in vitro studies incorporating techniques such as MeRIP-Seq with follow-up 
in human subjects. Work performed in cell lines or, preferably, animal models could be used 
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to identify those transcripts (or other RNA molecules) showing alteration in their 
modifications in response to exposures, with the idntified transcripts taken forward for 
target-specific analysis by more focussed and cost-effective approaches. 
 So, where are we now and where will we go? There is some early evidence that 
environmental exposures influence the expression of RNA methylation modulators, but 
largely without further analysis of the epitranscriptome. We suggest that the key next step is 
to perform transcriptome-wide analysis of RNA modifications in animal models under 
exposure to reveal targets for follow-up in human population studies. Global analysis of m6A, 
m1A and m5C may still serve as proof-of-principle and support the development of future 
studies, but it is unlikely to provide lasting insight into disease processes. 
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Table 1. Effect of Benzo(A)pyrene on RNA modification-related genes  
 Type Tissue Genes Analysis ↑/↓ Ref. 
m6A 
In vitro HepG2 Cells METTL3 Expression ↑ (Souza et al., 2016) 
Mouse Aorta METTL3 Expression ↑ 
(Kerley-Hamilton et al., 
2012) 




WTAP  Expression ↑ (Perez et al., 2008) 
In vitro HepG2 Cells FTO  Expression ↓ (Souza et al., 2016) 
In vitro HepG2 FTO  Expression ↓ 
(Magkoufopoulou et al., 
2011) 
In vitro HepG2 and HepaRG  FTO  Expression ↓ (Jennen et al., 2010) 
Mouse Aorta ALKBH5 Expression ↑ 
(Kerley-Hamilton et al., 
2012) 
Mouse Liver Tissue HNRNPC Expression ↓ (Malik et al., 2012) 
Mouse Aorta HNRNPC Expression ↑ 
(Kerley-Hamilton et al., 
2012) 
Mouse Different Organs HNRNPA2B1 Expression ↑ (Shi et al., 2010) 
In vitro MCF-7 Cells HNRNPA2B1 Expression ↑ (Hooven and Baird, 2008) 
Rat Hippocampus YTHDF2 Expression ↓ (Qiu et al., 2011) 
Mouse Aorta YTHDF2 Expression ↑ 







Mouse Aorta TRMT6 Expression ↑ 
(Kerley-Hamilton et al., 
2012) 
In vitro 
Human mammary epithelial 
cells (HMEC) 
TRMT6 Mutagenesis ↑ (Severson et al., 2014) 
Mouse Aorta TRMT10C Expression ↑ 
(Kerley-Hamilton et al., 
2012) 
In vitro HepG2 cells TRMT61B Expression ↓ 
(Magkoufopoulou et al., 
2011) 
m5C 
In vitro HepG2 Cells NOP2 Expression ↑ (Souza et al., 2016) 
Mouse Primary mouse hepatocytes NSUN4 Expression ↓ (Mathijs et al., 2009) 




Table 2. Effect of Bisphenol A on RNA modification-related genes 
 Type Tissue Genes Analysis ↑/↓ Ref. 
m6A 
In vitro 
Human Fetal Lung 
Fibroblasts 








WTAP Expression ↑ (Ali et al., 2014) 




FTO Expression ↓ (Ali et al., 2014) 
Mice Placenta FTO Expression ↑ (Tait et al., 2015) 
Rat Mammary Gland FTO Methylation ↑ (Jadhav et al., 2017) 
In vitro 
Human Fetal Lung 
Fibroblasts 




HNRNPC Expression ↑ (Ali et al., 2014) 
Rat Mammary Gland HNRNPC Methylation ↑ (Jadhav et al., 2017) 
In vitro 
Human Fetal Lung 
Fibroblasts. 








YTHDF2 Expression ↑ (Ali et al., 2014) 
Rat Mammary Gland YTHDF1 Expression ↑ (Jadhav et al., 2017) 
m1A 
Rat Seminiferous tubule TRMT61A Expression ↑ (Ali et al., 2014) 
In vitro 
Human fetal lung 
fibroblasts 
TRMT6 Expression ↓ (Mahemuti et al., 2018) 
Rat Seminiferous tubule TRMT6 Expression ↑ (Ali et al., 2014) 
Rat Seminiferous tubule TRMT10C Expression ↑ (Ali et al., 2014) 
Rat Seminiferous tubule ALKBH3 Expression ↑ (Ali et al., 2014) 
Mouse Tail tissue ALKBH3 Methylation ↑ (Jadhav et al., 2017) 
Rat Seminiferous tubule ALKBH1 Expression ↓ (Ali et al., 2014) 
m5C 
In vitro 
Human fetal lung 
fibroblasts 
NSUN2 Expression ↓ (Mahemuti et al., 2018) 
Rat Seminiferous tubule NSUN2 Expression ↑ (Ali et al., 2014) 
ED: Endocrine Disruptor, POP: Persistent Organic Pollutants, Increase (↑) or decrease (↓) 






Table 3. Effect of pesticides on RNA modification-related genes 
 
 Type Tissue Genes Analysis ↑/↓ Ref. 
m6A 
Zebrafish* Embryos METTL14 Expression ↑ (Wirbisky et al., 2015) 
In vitro* Embryonic Stem Cell ALKBH5 Expression ↓ (Midic et al., 2016) 
Zebrafish* Embryos ALKBH5 Expression ↑ (Wirbisky et al., 2015) 
In vitro* SH-SY5Y Cells YTHDF1 Expression ↑ (Koo et al., 2012) 
Rat** Ovary HNRNPA2B1 Expression ↓ (Nilsson et al., 2012) 
Rat** Sertoli Cells HNRNPA2B1 Expression ↑ (Guerrero-Bosagna et al., 2013) 
m1A 
In vitro* SH-SY5Y cells ALKBH3 Expression ↓ (Koo et al., 2012) 
Zebrafish* Embryos TRMT6 Expression ↑ (Wirbisky et al., 2015) 
Rat** Brain TRMT10C Expression ↓ (Crews et al., 2012) 
Rat** Different tissues TRMT10C Expression ↑ (Skinner et al., 2012) 
m5C 
In vitro* SH-SY5Y cells NSUN2 Expression ↓ (Koo et al., 2012) 
In vitro*** K562 cell  NOP2 Methylation ↑ (Zhang et al., 2012) 
Rat**** Urinary bladder NSUN4 Expression ↑ (Ihlaseh et al., 2011) 
Increase (↑) or decrease (↓) 
















Table 4. Effect of metals on RNA modification-related genes 




APL cell line 
NB4 
METTL3 Expression ↓ (Zheng et al., 2005) 
In vitro BEAS-2B WTAP Expression ↓ (Clancy et al., 2012) 
Copper Sulfate In vitro HepG2 Cells METTL14  Expression ↑ (Song et al., 2009) 
Cupric Oxide  In vitro 
Lung Epithelial 
A549 Cell 
METTL14  Expression ↑ (Hanagata et al., 2011) 
Copper 
 
In vitro Fibroblast Cell HNRNPA2B1 Expression ↑ 
(Armendariz et al., 
2006) 
Mouse Liver HNRNPA2B1 Expression ↑ (Burkhead et al., 2011) 
Cobaltous Chloride 
In vitro 
Rat Liver Derived 
Cell Lines 
ALKBH5 Expression ↑ (Permenter et al., 2013) 








YTHDF1 Expression ↑ (Wu et al., 2012) 
m1A 
Copper Sulfate  
In vitro HepG2 TRMT61B Expression ↓ (Song et al., 2009) 
In vitro HepG2 ALKBH1 Expression ↓ (Song et al., 2009) 
Methylmercuric 
chloride  
Zebrafish  Embryos ALKBH3 Expression ↓ (Ho et al., 2013) 
Zebrafish  Embryos ALKBH3 Expression ↓ (Yang et al., 2007) 
m5C 
Nickel Human Skin NOP2 Expression ↑ 
(da Rosa et al., 2015; 
Dhingra et al., 2014) 
Nickel Zebrafish Total fish NOP2 Expression ↑ 
(Hussainzada et al., 
2014) 
Nickel Human Skin NSUN4 Expression ↑ 
(da Rosa et al., 2015; 
Dhingra et al., 2014) 
Lead Human Peripheral blood NSUN3 Expression ↑ (LaBreche et al., 2011) 













Figure 1: Enzymatic regulation of RNA methylation. The m6A, m1A and m5C RNA 
modifications are added to RNA molecular by 'writer' methyltransferases (green), remove by 
'eraser' demethylases (red) and utilised by 'readers' (blue). Examples of modifications (orange 
circles) to mRNA and tRNA molecules are illustrated. 
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